While overexpression of pRB in primary tumours is not invariably associated with better prognosis (Cote et al, 1998), the finding of an intrinsic GrB directly expressed by human nonlymphoid tumour cells adds a new dimension to the clinical research on potential prognostic value of pRB expression in primary cancers. The gene discussed is RB1; the disease is cancer.